Skip to main content
Caplight Logo









Fin-X

Fin-X

Private
São PauloHealthcare & Life Scienceshttps://finxapp.com.br/

Last Round

Pre Seed

Apr 30, 2025

Total Funding Raised

$4.07M

Company Overview

Fin-X operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Pre Seed round in April 2025.

Fin-X is a health-tech company that provides a digital platform for managing surgical journeys, integrating hospitals, physicians, and health insurance operators to improve efficiency and financial transparency.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Vertical SaaS, Digital Payments, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Payment Processing Fee, Usage-Based SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Fin-X Comparables

Compare Fin-X with similar companies based on industry and business-model similarity.

Fin-X comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Intelectah
82%
MedSimples
76%
Rivio Tech
72%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Fin-X Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedApr 30, 2025
SeedMar 24, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Fin-X Investors

Notable investors and investment history

Fin-X investors
InvestorRounds
DOMO.VCPre Seed, Seed
XP Asset ManagementSeed
HeadlinePre Seed
AtlanticoPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Monthly visitors increased 48% MoM.

  • Nov 12, 2025

    Monthly visitors increased 110% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Fin-X Filings

Explore SEC and related filing metadata, where available.

Fin-X filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Fin-X's valuation, stock price, and market status.

Is Fin-X a public or private company?

Fin-X is a private company.

What is the current stock price of Fin-X?

Fin-X is a private company, so its shares have no public market price. Caplight tracks Fin-X's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Fin-X worth (valuation)?

Valuation information for Fin-X is not publicly available.

Can I buy Fin-X stock?

Fin-X shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Fin-X's last funding round?

Fin-X's most recent funding round was Pre Seed on April 30, 2025.

Who are the main investors in Fin-X?

Key investors in Fin-X include XP Asset Management, Atlantico.

Will Fin-X IPO soon?

No public IPO plans have been announced for Fin-X.

How can I track Fin-X secondary market activity?

Caplight tracks bids, offers, and trades in Fin-X's shares on secondary markets.

Firmographic Details

HeadquartersSão Paulo
Employee Range80
Year Founded2017
Last FundingApr 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?